Public Company

Brainstorm Cell Therapeutics

BrainStorm is a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases.


Brainstorm Cell Therapeutics Inc. is a developer of autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The company holds the rights to clinical development and commercialization of the NurOwn technology platform used to produce autologous MSC-NTF cells through an exclusive, worldwide licensing agreement. Autologous MSC-NTF cells have received Orphan Drug designation status from the FDA and the EMA for the treatment of amyotrophic lateral sclerosis (ALS).


Founded 2004
Type Public
Longevity related Yes
Location New York, New York, USA

Recent Jobs at Brainstorm Cell Therapeutics

Latest News


BCLI $0.34 -7.67% $(0.03)